|
|
|
|
LEADER |
01051caa a2200301 ir4500 |
001 |
NSK01000166763 |
003 |
HR-ZaNSK |
005 |
20190115115726.0 |
008 |
960520s1995 ci ||| ||eng |
035 |
|
|
|9 (HR-ZaNSK)166963
|
035 |
|
|
|9 (HR-ZaNSK)960520013
|
035 |
|
|
|a (HR-ZaNSK)000166763
|
040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
041 |
0 |
|
|a eng
|b hrv
|
080 |
|
|
|a 615.276
|
080 |
|
|
|a 615.22
|
100 |
1 |
|
|a Kidwai, Mazzahir
|
245 |
1 |
0 |
|a Novel 1,2,4-triazole, 1,3,4-thiadiazole and 1,3,4-oxadiazole derivatives and their pharmacological screening /
|c Mazaahir Kidwai, Neena Negi, S. R. Chowdhury.
|
300 |
|
|
|b Ilustr.
|
504 |
|
|
|a Bibliografija: 11 jed
|
504 |
|
|
|a Sažetak
|
653 |
0 |
|
|a Lijekovi, testiranja
|a Antiflogistici
|a Kardiovaskularni agensi
|
700 |
1 |
|
|a Chowdhury, S. R.
|
773 |
0 |
|
|t Acta pharmaceutica (Zagreb)
|x 1330-0075
|g 45 (1995), 4 ; str. 511-516
|w nsk.(HR-ZaNSK)000054908
|
932 |
|
|
|a da
|b znanstveni rad
|
981 |
|
|
|p CRO
|z B5/95
|
998 |
|
|
|c SBN, 199610
|c ikak9805
|c jvlp9806
|
886 |
0 |
|
|2 unimarc
|b 00846iaa2 2200241 450
|